covid-19 Ventilators medicines patient Coronavirus

Gilead’s remdesivir mainly helped healthier coronavirus patients

Reading now: 463
www.livemint.com

Gilead Sciences Inc.’s remdesivir, the first medicine cleared for the treatment of Covid-19, mainly benefited healthier patients who weren’t dependent on ventilators or heart-lung bypass machines, according to published results of the study used to get the medicine on the market.

The drug helped patients infected with the novel coronavirus heal faster, allowing them to return home after about 11 days, compared to 15 days for those who were treated with a placebo, according to the report in the New England Journal of Medicine.

There were also signs the medicine increased their survival rate -- 7.1% on patients on remdesivir and 11.9% on a placebo died within two weeks.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA